GLPwatch
Soliqua for Anxiety
lixisenatide · Investigational / off-label
Last updated 2026-05-28 15:46 UTCSoliqua (lixisenatide) is not FDA-approved for anxiety, and any use for this condition is off-label or investigational. Research shows that lixisenatide crosses the blood-brain barrier and enhances neurogenesis, but this does not establish a link to anxiety treatment.
AI summary of the sources below.
| Drug | Soliqua (lixisenatide) |
|---|---|
| Condition | Anxiety |
| Approval status | Investigational / off-label |
| Research papers | 1 |
Soliqua is not FDA-approved for anxiety; the research below reflects investigational or off-label study only.